![Kevin Moulder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Kevin Moulder served as the Chief Development Officer at Tusk Therapeutics Ltd. from 2015 to 2018.
He then worked as the Chief Operating Officer at Polyprox Therapeutics Ltd. from 2018 to 2021.
In 2021, he became the Chief Scientific Officer at Medicenna Therapeutics Corp.
Dr. Moulder also held the position of Chief Scientific Officer at F-star Therapeutics Ltd. Dr. Moulder received a graduate and doctorate degree from the University of London.
Former positions of Kevin Moulder
| Companies | Position | End |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Chief Tech/Sci/R&D Officer | 2022-03-02 |
Polyprox Therapeutics Ltd.
 Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases | Chief Operating Officer | 2021-01-31 |
Tusk Therapeutics Ltd.
 Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 2018-08-31 |
F-star Therapeutics Ltd.
 F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops antibodies therapeutics for cancer therapy | Chief Tech/Sci/R&D Officer | - |
Training of Kevin Moulder
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tusk Therapeutics Ltd.
Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Medicenna Therapeutics Corp.
 Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Polyprox Therapeutics Ltd.
Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases | Health Technology |
F-star Therapeutics Ltd.
F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops antibodies therapeutics for cancer therapy | Health Technology |
- Stock Market
- Insiders
- Kevin Moulder
